within Pharmacolibrary.Drugs.ATC.A;

model A06AD01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.06666666666666667,
    adminDuration  = 600,
    adminMass      = 1.0,
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Magnesium carbonate is an inorganic salt used as a magnesium supplement. It is commonly employed as an antacid to relieve symptoms of indigestion and heartburn and to correct magnesium deficiency. Magnesium carbonate is still available and used for such purposes today. It is classified under ATC code A06AD01 in the laxatives category, specifically as a saline laxative.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults, orally administered. No specific clinical pharmacokinetic studies for magnesium carbonate identified; parameters estimated based on general pharmacokinetics of orally administered inorganic magnesium salts.</p><h4>References</h4><ol><li><p>Kim, KS, et al., &amp; Choi, HG (2016). Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer. <i>Archives of pharmacal research</i> 39(4) 531–538. DOI:<a href=&quot;https://doi.org/10.1007/s12272-015-0701-9&quot;>10.1007/s12272-015-0701-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26992922/&quot;>https://pubmed.ncbi.nlm.nih.gov/26992922</a></p></li><li><p>Aideloje, SO, et al., &amp; Ugwu, NC (1998). Altered pharmacokinetics of halofantrine by an antacid, magnesium carbonate. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 46(3) 299–303. DOI:<a href=&quot;https://doi.org/10.1016/s0939-6411(98)00029-0&quot;>10.1016/s0939-6411(98)00029-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9885302/&quot;>https://pubmed.ncbi.nlm.nih.gov/9885302</a></p></li><li><p>Zardán Gómez de la Torre, T, et al., &amp; Strømme, M (2022). Bioavailability of Celecoxib Formulated with Mesoporous Magnesium Carbonate-An In Vivo Evaluation. <i>Molecules (Basel, Switzerland)</i> 27(19) –. DOI:<a href=&quot;https://doi.org/10.3390/molecules27196188&quot;>10.3390/molecules27196188</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36234733/&quot;>https://pubmed.ncbi.nlm.nih.gov/36234733</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A06AD01;
